KamulinBiotechco.ltd / RuixiBiotechCo.Ltd

89Zr-trastuzumab is a molecular imaging agent used for positron emission tomography (PET) imaging. It consists of the monoclonal antibody trastuzumab, which specifically targets the human epidermal growth factor receptor 2 (HER2), labeled with the radioisotope zirconium-89 (89Zr).This radiopharmaceutical facilitates non-invasive imaging of HER2-positive tumors, aiding in the assessment of the extent and distribution of HER2 expression in various cancers. This imaging can be crucial for treatment planning, monitoring response to therapy, and disease staging, particularly in breast cancer. #radioisotope #zirconium-#89 (#893Zr)-#trastuzumab #molecular #imaging https://lnkd.in/gjn4U_xC

68Ga-FAPI-04 is a radiopharmaceutical used in positron emission tomography (PET) imaging for the visualization of fibroblast activation protein (FAP) in various cancers. FAP is found in the tumor stroma of many epithelial cancers, and its imaging with 68Ga-FAPI-04 can help in staging, restaging, and therapy response assessment. The tracer ability to target FAP allows for precise imaging of the tumor microenvironment, aiding in the characterization of tumors and potentially influencing treatment decisions. This development presents a significant advancement in the field of molecular imaging and targeted cancer diagnostics. #68Ga-#FAPI-#04 #radiopharmaceutical #fibroblast #activation #protein (#FAP) #imaging #tracer https://lnkd.in/ghnTtrWk

Cyluc1,CAS 1247879-16-8 is a synthetic cyclic alkylamino luciferin that exhibits superior properties in in in vivo imaging due to its red shift luminescence compared to D-luciferin. It has a higher affinity for binding to luciferase and releases about 5.7 times more light than amino luciferin, and 3.2 times brighter than D-luciferin. Its excellent light output can be maintained over a wide range (1-100) μM) . #Cyluc1,#CAS# 1247879-#16-#8 #cyclic #alkylamino #luciferin #exhibits #superior #properties https://lnkd.in/gHM-kgnk

177Lu-Pentixather is an emerging radiopharmaceutical used in targeted radionuclide therapy. Pentixather is a small molecule that selectively binds to the CXCR4 receptor. By combining this targeting molecule with Lutetium-177, which emits beta particles, it becomes possible to deliver targeted radiation to cells that overexpress the CXCR4 receptor. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #177Lu-#Pentixather #targeted #radionuclide #therapy #CXCR4 #receptor #Lutetium-#177 https://lnkd.in/gtGmzx-D

68Ga-Pentixafor is a radiopharmaceutical used in molecular imaging for visualizing the expression of the CXCR4 receptor, which is involved in various diseases, including cancer and inflammatory conditions. This radiotracer, labeled with gallium-68, is particularly useful in positron emission tomography (PET) imaging to locate and assess the expression of CXCR4. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #68Ga-#Pentixafor #molecular #imaging #CXCR4 #receptor #radiotracer #gallium-#68 #positron #emission #tomography (#PET) #imaging https://lnkd.in/gDzBPvqH

68Ga-PSMA-11 is a radiopharmaceutical used in positron emission tomography (PET) imaging for detecting prostate cancer. This radiotracer targets prostate-specific membrane antigen (PSMA), a protein that is overexpressed in prostate cancer cells, allowing for highly specific imaging of prostate cancer. When injected into the body, the radioactive gallium-68 emits positrons that generate signals picked up by the PET scanner, providing highly detailed images of the distribution and concentration of PSMA in the body. This imaging helps in the initial staging, restaging, and monitozring of prostate cancer, and it can be useful in guiding treatment decisions. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #68Ga-#PSMA-#11 #detecting #prostate #cancer #radiotracer #targets #prostate-#specific #membrane #antigen https://lnkd.in/gXXKxP2h

64Cu-177Lu-DOTATATE is a theranostic radiopharmaceutical used in nuclear medicine for the diagnosis and treatment of neuroendocrine tumors (NETs). It combines the diagnostic properties of 64Cu and the therapeutic properties of 177Lu with the targeting molecule DOTATATE, which binds to somatostatin receptors commonly found on NET cells. This approach allows for both imaging and treatment of tumors, offering a personalized medicine option for patients with NETs. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #64Cu-#177Lu-#DOTATATE #theranostic #radiopharmaceutical #targeting #molecule #imaging and #treatment of #tumors #kg #level #cost#effective https://lnkd.in/gv75v82Y

68Ga-DOTATATE/Gallium-68 DOTATATE/68Gallium-DOTATATE is emerging as the most sensitive and specific imaging agent. It can be used to diagnose a well-differentiated neuroendocrine tumor. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #68Ga-#DOTATATE/#Gallium-#68 #DOTATATE/#68Gallium-#DOTATATE #emerging #imaging #diagnose #neuroendocrine #tumor #kg #level #cost-#effective https://lnkd.in/gp6m5p9v

The target of TLX591-CDx is PSMA, which can be used for imaging diagnosis of prostate cancer. We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #TLX591-#CDx #prostate #cancer #kg #level #cost-#effective https://lnkd.in/g8X89weh

The target site of 90Y-ibritumomab tiuxetan is CD20, which can be used for the treatment of refractory non Hodgkin lymphoma. We can mass produce (kg level), process scaling up, pilot supply, raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. #90Y-#ibritumomab #tiuxetan #target #site #CD20 #refractory #non #Hodgkin #lymphoma https://lnkd.in/edUtjNkf